IN2014DN11097A - - Google Patents

Download PDF

Info

Publication number
IN2014DN11097A
IN2014DN11097A IN11097DEN2014A IN2014DN11097A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A IN 11097DEN2014 A IN11097DEN2014 A IN 11097DEN2014A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A
Authority
IN
India
Prior art keywords
particles
titanium
micrometer
cavities
exhibit
Prior art date
Application number
Inventor
Lars Magnus Bjursten
Sven Erik Nilsson
Original Assignee
Migrata U K Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migrata U K Ltd filed Critical Migrata U K Ltd
Publication of IN2014DN11097A publication Critical patent/IN2014DN11097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres

Abstract

The present invention describes particles of titanium titanium alloy at least one type of titanium oxide or a combination thereof wherein at least a substantial amount of the particles are of micrometer millimeter size and are non spherical for use as an X ray contrast agent. The irregular shapes and/or internal pores and cavities of said particles lead to a prolonged retention time in the gastrointestinal tract leading to a longer time period available for X ray examination. Further the particles are not only chemically inert they also exhibit an anti inflammatory and anti bacterial effect on the surrounding tissue.
IN11097DEN2014 2012-06-04 2013-05-29 IN2014DN11097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261655093P 2012-06-04 2012-06-04
SE1250582 2012-06-04
PCT/SE2013/050620 WO2013184061A1 (en) 2012-06-04 2013-05-29 Medical use of particles of titanium and/or titanium oxide

Publications (1)

Publication Number Publication Date
IN2014DN11097A true IN2014DN11097A (en) 2015-09-25

Family

ID=49712337

Family Applications (1)

Application Number Title Priority Date Filing Date
IN11097DEN2014 IN2014DN11097A (en) 2012-06-04 2013-05-29

Country Status (5)

Country Link
US (1) US20150139913A1 (en)
EP (1) EP2854868A4 (en)
CN (1) CN104736184A (en)
IN (1) IN2014DN11097A (en)
WO (1) WO2013184061A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2968619B1 (en) * 2013-03-15 2021-08-11 The Regents of the University of California Enteric ct contrast material based on low-z atoms
CN113456839B (en) * 2021-07-05 2022-06-21 浙江大学 Dipole resonance enhanced double-negative acoustic metamaterial and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020152A (en) * 1973-12-18 1977-04-26 Thann & Mulhouse Barium titanate and barium zirconate in radiological contrast products
EP0253554A3 (en) * 1986-07-15 1988-07-20 Pfizer Inc. Controlled release drug-containing fibers
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions
US5593657A (en) * 1995-02-09 1997-01-14 Nanosystems L.L.C. Barium salt formulations stabilized by non-ionic and anionic stabilizers
US6024569A (en) * 1998-11-06 2000-02-15 Aytec Japan Corporation Root canal filling point
SE515227C2 (en) * 1999-04-28 2001-07-02 Bruce Medical Ab Body for providing and growing bone and / or connective tissue and methods for making the body
DE10018405B4 (en) * 2000-04-13 2004-07-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Spherical oxidic particles and their use
US6394965B1 (en) * 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
MXPA04009194A (en) * 2002-03-22 2005-06-20 Kuros Biosurgery Ag Composition for hard tissue augmentation.
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
JP4474878B2 (en) * 2003-09-17 2010-06-09 株式会社Ｉｈｉ X-ray contrast medium and method for producing X-ray contrast medium
EP1828056A1 (en) * 2004-11-02 2007-09-05 Nanogate AG Synthesis of titanium dioxide nanoparticles
SE531318C2 (en) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injectable suspension comprising microstructure titanium titanium, titanium alloy or titanium oxide particles
JP2008297289A (en) * 2007-06-04 2008-12-11 Canon Inc Contrast medium and production method thereof
JP5623408B2 (en) * 2008-09-30 2014-11-12 サビック イノベーティブ プラスチックスイーペー ベスローテン フェンノートシャップ X-ray and / or metal detectable article and method for producing the same
GB0921596D0 (en) * 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
US20120307962A1 (en) * 2009-12-16 2012-12-06 Georgia Tech Resarch Corporation Systems and methods for x-ray fluorescence computed tomography imaging with nanoparticles

Also Published As

Publication number Publication date
EP2854868A1 (en) 2015-04-08
US20150139913A1 (en) 2015-05-21
EP2854868A4 (en) 2016-01-20
WO2013184061A1 (en) 2013-12-12
CN104736184A (en) 2015-06-24

Similar Documents

Publication Publication Date Title
CA2865972C (en) Inhalable dry powders
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
SG10201402069PA (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2010090855A3 (en) Oral care composition to reduce or eliminate dental sensitivity
IN2014DN08882A (en)
IL234101B (en) Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
EP3686184A3 (en) Ionizable compounds and compositions and uses thereof
PL2588114T3 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
EP2480687A4 (en) Methods and compositions for the diagnosis and treatment of thyroid cancer
WO2014144295A8 (en) Ceftolozane antibiotic compositions
WO2012138379A3 (en) Multifunctional chelator-free radioactive nanoparticles for imaging and therapy
BR112012004967A2 (en) oral dosage form comprising at least one biologically active agent, formulation aids and magnetizable particles
HK1222562A1 (en) Compositions and methods for use in medical diagnosis
JP2012528941A5 (en)
PT2523674E (en) Compositions comprising andrographis paniculata extracts combined with ginkgo biloba extracts complexed with phospholipids, and their use
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
WO2015073177A8 (en) Vaginal inserted estradiol pharmaceutical compositons and methods
IL238937A0 (en) Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states
IN2014DN11097A (en)
HK1211220A1 (en) A pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
WO2015054208A8 (en) Injectable compositions
PT2603238E (en) Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
MX2018004445A (en) Colloidal particles for use in medicine.
WO2014031982A3 (en) Methods and compositions for treating pain